Risk adjustment solutions for Medicare Advantage organizations are entering 2027 under a confirmed payment environment and a set of operational changes that require adaptation before January 1. CMS's April 2026 Rate Announcement projects MA payments to increase by 2.48% – over $13 billion – in CY 2027, while CMS expects MA risk scores to increase by 2.50% on average due to underlying coding trends [1]

Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to col...
read more
For clinical laboratory and pathology executives, 2026 presents a reimbursement landscape that looks fundamentally diffe...
read more
The PAMA reporting window for clinical laboratories is open right now – May 1 through July 31, 2026. What applicable lab...
read more
The conversation around fraud in laboratory billing, especially in genetic and molecular diagnostics, is no longer theor...
read more
In today’s US healthcare market, laboratory revenue cycle management (lab RCM) is no longer just about clean billing – i...
read more
Artificial Intelligence (AI) is steadily reshaping digital pathology – but not through sudden disruption or autonomous d...
read more
Medicare clawbacks related to urinary tract infection (UTI) testing are no longer isolated compliance events. As we move...
read more
With telehealth now a mainstream mode of care, many pathology labs, clinical laboratories, and behavioral health provide...
read more
The 2025 Clinical Laboratory Fee Schedule (CLFS) update has given U.S. labs extra time to prepare for the upcoming Janua...
read more